We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

64 hedge funds and large institutions have $214M invested in Corcept Therapeutics in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 4

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

99% more capital invested

Capital invested by funds: $108M → $214M (+$107M)

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

29% more call options, than puts

Call options by funds: $49K | Put options by funds: $38K

23% more funds holding

Funds holding: 52 → 64 (+12)

Holders
64
Holders Change
+12
Holders Change %
+23.08%
% of All Funds
1.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
16
Increased
20
Reduced
13
Closed
4
Calls
$49K
Puts
$38K
Net Calls
+$11K
Net Calls Change
-$55K

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$3.36M
2
ISL
Ingalls & Snyder LLC
New York
+$2.7M
3
Invesco
Invesco
Georgia
+$1.01M
4
EI
EAM Investors
California
+$813K
5
RFC
Russell Frank Company
Washington
+$707K

Top Sellers

Rank Fund Capital Flow
1
IA
Investor AB
Sweden
-$1.32M
2
CIA
Capital Impact Advisors
Massachusetts
-$179K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$73.1K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$51.5K
5
SIM
Spark Investment Management
New York
-$50K
Name Holding Trade Value Shares
Change 		Change in
Stake
SB
26
Suntrust Banks
Georgia
$362K -$27.2K -7,500 -10%
Deutsche Bank
27
Deutsche Bank
Germany
$358K +$69.5K +19,200 +43%
PPA
28
Parametric Portfolio Associates
Washington
$313K +$130 +36 +0.1%
Renaissance Technologies
29
Renaissance Technologies
New York
$310K +$201K +55,400 New
CT
30
Cambridge Trust
Massachusetts
$280K – – –
ARTA
31
A.R.T. Advisors
New York
$274K +$178K +49,078 New
MLICM
32
Metropolitan Life Insurance Company (MetLife)
New York
$246K +$159K +44,002 New
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$243K +$36.6K +10,100 +30%
SIM
34
Spark Investment Management
New York
$240K -$50K -13,800 -24%
AQR Capital Management
35
AQR Capital Management
Connecticut
$236K -$73.1K -20,200 -32%
NFA
36
Nationwide Fund Advisors
Ohio
$219K -$5.66K -1,562 -4%
BA
37
BlackRock Advisors
Delaware
$214K +$7.32K +2,021 +6%
Nomura Holdings
38
Nomura Holdings
Japan
$191K +$131K +36,298 New
HCM
39
Highbridge Capital Management
New York
$190K +$123K +34,036 New
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$189K +$76.8K +21,228 +169%
AIG
41
American International Group
New York
$188K – – –
CS
42
Credit Suisse
Switzerland
$150K +$24.3K +6,704 +34%
Millennium Management
43
Millennium Management
New York
$144K +$93.2K +25,745 New
BSW
44
Buckingham Strategic Wealth
Missouri
$112K – – –
WS
45
Wedbush Securities
California
$112K – – –
William Blair & Company
46
William Blair & Company
Illinois
$112K – – –
PP
47
PDT Partners
New York
$81K +$52.1K +14,400 New
Citadel Advisors
48
Citadel Advisors
Florida
$75K +$48.3K +13,344 New
TC
49
TFS Capital
Pennsylvania
$73K +$47.1K +13,006 New
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$60K – – –
1
2
3

CORT Hedge Fund Activity: Q1 2015 in Review

64 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2015, worth a combined $214M — up 99% from $108M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CORT positions and 4 closed out — a net gain of 12 holders — while 20 added to existing stakes and 13 trimmed.

The largest buyer was Federated Hermes, adding an estimated $3.36M. The largest seller was Investor AB, cutting an estimated $1.32M.

  • 64 institutional investors held Corcept Therapeutics (CORT) as of Q1 2015, up from 52 in Q4 2014.
  • Funds reported $214M of Corcept Therapeutics stock for Q1 2015, up 99% quarter-over-quarter.
  • 16 funds opened new Corcept Therapeutics positions in Q1 2015 and 4 closed out, a net change of +12 holders.
  • The largest Corcept Therapeutics buyer in Q1 2015 was Federated Hermes, an estimated $3.36M added.
  • The largest Corcept Therapeutics seller in Q1 2015 was Investor AB, an estimated $1.32M sold.

Based on aggregated 13F filings for Q1 2015.